Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation

By Mukherjee S.   Rogge J.   Weaver L.   Schafer D.F.  

Transplantation Proceedings, Vol. 35, Iss. 8, 2003-12 ,pp. : 3042-3044

Elsevier

Access to resources Recommend Favorite

Effect of interferon-alfa treatment in renal transplant recipients with chronic hepatitis c

By Tokumoto T.   Tanabe K.   Ishikawa N.   Simizu T.   Oshima T.   Noguchi S.   Gouya N.   Nakazawa H.   Hashimoto E.   Fuchinoue S.   Hayashi N.   Toma H.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3270-3272

Elsevier

Access to resources Recommend Favorite

Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C

By Tokumoto T.   Tanabe K.   Ishikawa N.   Simizu T.   Oshima T.   Noguchi S.   Gouya N.   Nakazawa H.   Hashimoto E.   Fuchinoue S.   Hayashi N.   Toma H.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2887-2889

Elsevier

Access to resources Recommend Favorite

Histologic outcome of hepatitis C virus infection in renal transplant recipients and the effect of pretransplantation interferon treatment

By Gursoy M.   Bilezikci B.   Colak T.   Koksal R.   Demirhan B.   Karavelioglu D.   Boyacioglu S.   Bilgin N.   Arslan G.  

Transplantation Proceedings, Vol. 32, Iss. 3, 2000-05 ,pp. : 558-560

Elsevier

Access to resources Recommend Favorite

Hepatitis C infection in renal transplant recipients in Israel

By Weinstein T.   Zevin D.   Ori Y.   Korzets A.   Chagnac A.   Herman M.   Tur-Kaspa R.   Gafter U.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2696-2698

Elsevier

Access to resources Recommend Favorite